Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Antitumour T cells stand the test of time

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Nature 576, 392-393 (2019)



  1. Wei, J. et al. Nature 576, 471–476 (2019).

    Article  Google Scholar 

  2. Lim, W. A. & June, C. H. Cell 168, 724–740 (2017).

    Article  Google Scholar 

  3. Henning, A. N., Roychoudhuri, R. & Restifo, N. P. Nature Rev. Immunol. 18, 340–356 (2018).

    Article  Google Scholar 

  4. Zhang, L. & Romero, P. Trends Mol. Med. 24, 30–48 (2018).

    Article  Google Scholar 

  5. Matsushita, K. et al. Nature 458, 1185–1190 (2009).

    Article  Google Scholar 

  6. Iwasaki, H. et al. Nature Immunol. 12, 1167–1175 (2011).

    Article  Google Scholar 

  7. Uehata, T. et al. Cell 153, 1036–1049 (2013).

    Article  Google Scholar 

  8. Scharping, N. E. et al. Immunity 45, 701–703 (2016).

    Article  Google Scholar 

  9. Kurachi, M. et al. Nature Immunol. 15, 373–383 (2014).

    Article  Google Scholar 

  10. Miller, B. C. et al. Nature Immunol. 20, 326–336 (2019).

    Article  Google Scholar 

  11. Manguso, R. T. et al. Nature 547, 413–418 (2017).

    Article  Google Scholar 

Download references

Competing Interests

A.W.G. is on the SAB of Pandion Therapeutics and Arsenal Bio.


Nature Careers


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links